Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
PRO1184 1X9HDTV Distribution Amplifier
Genmab cans another ADC from ProfoundBio deal in area of J&J’s Ambrx buyout
Genmab launches “AI Everywhere” | OpenAI
Genmab Snaps Up Merus For $8bn In Search For Pipeline Boosters
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart ...
PRO1184 for Cancer Clinical Trial 2024 | Power
Rina-S (rinatabart sesutecan) / Genmab
PRO1184 for Mesothelioma Clinical Trial 2023 | Power
Genmab Announces Updated Results from Phase 2 EPCORE® NHL-6 Study ...
UCSD Ovarian Cancer Trial → Rinatabart Sesutecan (Rina-S, PRO1184 ...
Portfolio | Genmab 宣布收购普方生物，拓展并深化在肿瘤治疗领域的布局医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Transforming lives with pioneering antibody science | Genmab
Genmab bulks ADC pipeline with $1.8-billion purchase of ProfoundBio
Rinatabart Sesutecan | PRO1184 | Rina-S » ADC Review
FRα ADC Rina-S by Genmab Enters Late-Stage Clinical Trial Following ...
OREGA enters into a License Agreement with Genmab - Orega Biotech
Denmark: Genmab to broaden and strengthen oncology portfolio with ...
Genmab/普方生物：FRα ADC启动三期临床 Armstrong 2024年10月1日， Genmab 在Clinicaltrials ...
Genmab Stock Drops On Mixed Results From Late-Stage Trial Of Lymphoma Drug
Genmab unveils striking new site near Princeton
Genmab enters into collaboration with Traverse Biotech | MedWatch News
With $415M on the line, Genmab taps Synaffix for antibody-drug ...
#joingenmab #biotechjobs | Genmab
Genmab：准备好，袜子掉！ 接上篇二、产品介绍篇上篇小编介绍过， Genmab 有一个口号叫做：knock your socks off ...
Genmab | Our Purpose
Genmab Buys Merus For $8bn: A Good Deal If Potential Is Converted Into ...
HexElect®| Genmab
Genmab Accelerator - INTOS
生命资本客户普方生物被 Genmab 18 亿美元现金收购医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Genmab Antibody therapies for cancer
Genmab to acquire closely watched cancer drug in $8B Merus buyout ...
Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus - The ...
Genmab：终止开发PD-L1/4-1BB双抗 Armstrong 2025年12月29日， Genmab 宣布终止开发PD-L1/4 ...
Genmab broadens ADC pipeline with $1.8bn acquisition of ProfoundBio ...
Genmab Buys ProfoundBio for $1.8B to Boost Oncology Portfolio
#jpm2025 | Genmab
Genmab logo hi-res stock photography and images - Alamy
Genmab Stock: Recent Updates Support The Growth Narrative (NASDAQ:GMAB ...
Genmab halts enrollment for cancer drug from ProfoundBio buyout
Genmab to Acquire Merus for $8B, Expanding Bispecific Antibody Cancer ...
Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC
中国Biotech公司ADC产品技术特色
The High Hydrophilicity of ADC Linker Has Become the Main Trend in ...
普方生物两款ADC喜获新进展|PRO1184人体临床试验启动给药，PRO1160获FDA批准启动I期临床 - 知乎
18亿美元被收购！扒扒普方生物的管线和平台医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
普方生物两款ADC喜获新进展｜PRO1184人体临床试验启动给药，PRO1160获FDA批准启动I期临床_腾讯新闻
普方生物FRα ADC申报临床 11月18日，普方生物递交注射用PRO1184的临床试验获得CDE受理。PRO1184是一种ADC药物，通过 ...
18亿美元！普方生物被Genmab收购！第四家中国biotech，主打ADC - 知乎
普方生物：FRα ADC临床申请获受理 Armstrong 2022年11月18日，普方生物PRO184 注射液的临床试验申请获得NMPA受理 ...
普方生物宣布以FRα为靶点的ADC药物PRO1184已完成首例受试者给药医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Creating agent and human collaboration with GPT 4o | OpenAI
Abstract 1085: PRO1184, a novel folate receptor alpha-directed antibody ...
Abstract 6880: Rinatabart sesutecan (PRO1184) in combination with ...
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid ...
Abstract 2637: Novel folate receptor alpha-directed antibody-drug ...
EGFR突变肺癌、子宫内膜癌新药临床试验：ADC新药注射用PRO1184-印塔健康官网
临床进展丨普方生物：ADC药物PRO1184获得FDA临床许可医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
ProfoundBio Highlights Broad Antitumor Activity in Preclinical Models ...
ProfoundBio Receives FDA Approval for PRO1184, Appoints New CMO ...
Rinatabart sesutecan（PRO1184）联合标准治疗在卵巢癌模型中显示出协同作用 - 知乎
Genmab宣布18亿美元全现金收购普方生物|附PPT医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
PRO1184-10 1/8 Trencher X MT 3.8" M2 MX38 Raid Mounted Tires (2 ...
18 亿美元！Genmab收购普方生物，获得核心资产FRα ADC医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Novartis nabs cardio drug with $1.4bn Tourmaline buy | pharmaphorum
普方生物宣布以FRα为靶点的ADC药物PRO1184已完成首例受试者给药-美通社PR-Newswire
超7倍回报！ADC公司普方生物被Genmab以18亿美元全现金收购
4年无进展生存率达84.3%！强生/Genmab一线组合疗法3期结果亮眼
SEND Explorer Transforms Non-clinical Drug Development
18 亿美元！Genmab 收购普方生物_Rina-S_患者_治疗
Introducing Verdi, an AI dev platform powered by GPT-4o | OpenAI
AZ's ATR inhibitor ceralasertib flunks lung cancer test | pharmaphorum
slide73
An Overview of Genmab’s Drug Pipeline | Therapeutic Areas
Explore Career Opportunities at Genmab: Innovate in Biotech
Kickstart Your Career at Genmab: Early Career Opportunities
Genmab/AbbVie Partnered Blood Cancer Combination Drug…
中国Biotech公司ADC产品技术特色 2021年8月， 荣昌生物 就维迪西妥单抗与 Seagen 达成潜在总额高达26亿美元的授权交易 ...
技术梳理系列 | Genmab的Duomab平台
强生/Genmab一线组合疗法Darzalex Faspro 3期结果亮眼，治疗多发性骨髓瘤
Presented at SITC 2023: Streamlining T-cell engager development - AbCellera
Genmab：从“垂死挣扎”到“起死回生”！如何做到吸引大厂争相合作_摩熵医药
April 17 2023
Genmab：从“垂死挣扎”到“起死回生”！如何做到吸引大厂争相合作_摩熵医药(原药融云)
BioNTech退还Genmab的PDL1/4-1BB双抗医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Pro-Line Trencher X 3.8" Tire 1/2" Offset (2) (Black) [PRO1184-11-P ...
Genmab发表PD-L1/4-1BB双抗Acasunlimab的作用机制 - Book学术
Are you an ambitious Researcher who can be responsible for the ...
We are excited to share that data evaluating our investigational ...
),%20HER2-negative%20Breast%20Cancer,%20Hormone%20Receptor-positive%20Breast%20Cancer:%0A%0APRO1184%20for%20Mesothelioma.png?md=1)
:max_bytes(150000):strip_icc()/Our_Offices_Genmab_Copenhagen_Office_Building_3_Tuala_Hjarn-3cfaf9eb11c940918115c00204877f86.jpg)
-1723122146600.jpg)
